Status:

UNKNOWN

A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer

Lead Sponsor:

Linkoeping University

Collaborating Sponsors:

Universidade Nova de Lisboa

Conditions:

Breast Neoplasm

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Background: Internet-delivered interventions (IDI) can provide remarkable opportunities in addressing breast cancer (BC) survivors' unmet needs, as they present an effective strategy to improve care c...

Detailed Description

Background: Breast Cancer (BC) ranks as the most frequent and lethal cancer among women, in Portugal. However, advances in cancer detection and treatment contributed to a steady and significant increa...

Eligibility Criteria

Inclusion

  • Signed written informed consent.
  • Age ≥ 18 years;
  • Ability to read and write in Portuguese.
  • History of histologically or cytologically confirmed breast cancer with no evidence of metastatic disease.
  • An interval ≥ 6 month from primary adjuvant treatment completion (surgery, chemotherapy and/or radiotherapy), except for hormonal therapy.
  • Clinically significant symptoms of at least one of the following conditions: anxiety, depression, fatigue, insomnia and/or sexual dysfunction.
  • Ongoing regular psychoactive medication only accepted if dosage has been stable during the last 3 months.
  • Daily access to the Internet by computer and/or smartphone.
  • Ability to use a computer and/or smartphone and the internet.
  • No participation on any other interventional study or clinical trial.

Exclusion

  • Age ≤ 18 years;
  • Inability to co-operate and give informed consent.
  • Breast cancer not histologically or cytologically confirmed.
  • History of other malignancy within the last 5 years.
  • Metastasized breast cancer.
  • Current severe, uncontrolled systemic disease or mental disorder.
  • Absence of clinically significant symptoms.
  • Parallel ongoing psychological treatment.
  • Ongoing regular psychoactive medication if dosage has been changed during the last 3 months.
  • No access to the internet.
  • Inability to use a computer and/or smartphone and the internet.
  • Parallel ongoing participation in other interventional study or clinical trial.
  • Assessment by the investigator to be unable or unwilling to comply with the requirements of the protocol.

Key Trial Info

Start Date :

February 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT03275727

Start Date

February 1 2018

End Date

December 1 2019

Last Update

September 8 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.